Lab members

---

Robert obtained his MD and doctoral degree in immunology from LMU Munich, Germany. After his postdoc at UNC Chapel Hill, he was recruited to Columbia University in 2003. His goal is to use innovative approaches to better understand mechanisms of liver disease and develop novel treatments for fatty liver, fibrosis and cancer. Robert is also the inaugural director of Columbia's NIH P30-funded Digestive and Liver Disease Research Center (https://www.columbiadldrc.org)

Atsushi is a physician-scientist trained in GI and hepato-pancreato-biliary cancer surgery. He obtained a PhD from Osaka City University, Japan, and joined in the Schwabe lab in 2022. He is studying the role of hepatic stellate cells in liver function and liver cancer. Atsushi's is supported by a grant from the American Liver Foundation.

 Marcella obtained her MD from Marburg University and was trained in general surgery at Technical University, Munich, Germany. Marcella seeks to find novel therapeutic targets in hepatocellular by combining in vivo CRISPR screens and multimodal pharmacologic treatments with single cell-based analysis of transcriptional "master regulators" from patients. Marcella is supported by a grant from the German Research Foundation (DFG). 

Yana obtained her Ph.D. from the University of Groningen, Groningen, the Netherlands. She is interested in exploring novel therapeutic targets in cancer liver metastasis combining human data and mouse models. 

Qiuyan received her BS in Nutritional Sciences from Cornell University and joined the Schwabe lab in 2021 for her PhD thesis. She is interested in finding  therapeutic vulnerabilities for  intrahepatic cholangiocarcinoma. Outside lab, she is an amateur writer in science fictions. 

Jingran received his  B.S and BEc from Nanjing University, China and graduated in 2023 from Columbia University Biotech program. Jingran uses lentiviral CRISPRi in vitro screen to define novel therapeutic targets and synergies for the treatment of liver fibrosis and liver cancer.

Deqi graudated Medical School in China in 1983, and worked as physician majoring in infectious diseases. After working in the Kandel lab for over a decade, he joined the. Schwabe Lab, in 2016. Deqi supervises all transgenic mice for projects related to hepatic stellate cell biology and liver carcinogenesis.